Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
- 18 February 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 393 (3) , 555-559
- https://doi.org/10.1016/j.bbrc.2010.02.095
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA134225-01)
This publication has 15 references indexed in Scilit:
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumorsHuman Mutation, 2008
- Analysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathologica, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Anaplastic Thyroid CancerEndocrinology and Metabolism Clinics of North America, 2008
- Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomasInternational Journal of Oncology, 2008
- Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of ActivityJournal of Biological Chemistry, 2004
- The Human PICD Gene Encodes a Cytoplasmic and Peroxisomal NADP+-dependent Isocitrate DehydrogenaseJournal of Biological Chemistry, 1999
- Expression and Mutagenesis of Mammalian Cytosolic NADP+-Specific Isocitrate DehydrogenaseBiochemistry, 1997